ALZN
Alzamend Neuro, Inc.
NASDAQ · Healthcare · Biotechnology · US
$1.89
+2.72%Leverage
- Debt / equity
- 0.00x
- Net debt / equity
- -1.31x
- Debt / assets
- 0.00x
- Debt / EBITDA
- 0.00x
- Net debt / EBITDA
- 0.83x
Liquidity & coverage
- Current ratio
- 3.01x
- Quick ratio
- 3.01x
- Cash ratio
- 2.77x
- Interest coverage
- -818.59x
- EBITDA / interest
- -818.59x
- Working capital
- $5.5M
Cash & dividend
- FCF / debt
- —
- Cash flow / debt
- —
- Dividend per share
- —
- Dividend yield
- —
- Dividend growth 1y
- —
Leverage, liquidity, debt coverage and shareholder-distribution metrics · Data as of Jul 1, 2026